BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 26808548)

  • 1. The Toll-Like Receptor 4 (TLR4) Variant rs2149356 and Risk of Gout in European and Polynesian Sample Sets.
    Rasheed H; McKinney C; Stamp LK; Dalbeth N; Topless RK; Day R; Kannangara D; Williams K; Smith M; Janssen M; Jansen TL; Joosten LA; Radstake TR; Riches PL; Tausche AK; Lioté F; Lu L; Stahl EA; Choi HK; So A; Merriman TR
    PLoS One; 2016; 11(1):e0147939. PubMed ID: 26808548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association analysis of the beta-3 adrenergic receptor Trp64Arg (rs4994) polymorphism with urate and gout.
    Fatima T; Altaf S; Phipps-Green A; Topless R; Flynn TJ; Stamp LK; Dalbeth N; Merriman TR
    Rheumatol Int; 2016 Feb; 36(2):255-61. PubMed ID: 26410617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pleiotropic effect of the ABCG2 gene in gout: involvement in serum urate levels and progression from hyperuricemia to gout.
    Wrigley R; Phipps-Green AJ; Topless RK; Major TJ; Cadzow M; Riches P; Tausche AK; Janssen M; Joosten LAB; Jansen TL; So A; Harré Hindmarsh J; Stamp LK; Dalbeth N; Merriman TR
    Arthritis Res Ther; 2020 Mar; 22(1):45. PubMed ID: 32164793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-Like receptor 4 (TLR4) polymorphism rs2149356 and risk of gout in a Spanish cohort.
    Torres RJ
    Nucleosides Nucleotides Nucleic Acids; 2020; 39(10-12):1424-1431. PubMed ID: 32552358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The SLC2A9 nonsynonymous Arg265His variant and gout: evidence for a population-specific effect on severity.
    Hollis-Moffatt JE; Gow PJ; Harrison AA; Highton J; Jones PB; Stamp LK; Dalbeth N; Merriman TR
    Arthritis Res Ther; 2011 Jun; 13(3):R85. PubMed ID: 21658257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replication of association of the apolipoprotein A1-C3-A4 gene cluster with the risk of gout.
    Rasheed H; Phipps-Green AJ; Topless R; Smith MD; Hill C; Lester S; Rischmueller M; Janssen M; Jansen TL; Joosten LA; Radstake TR; Riches PL; Tausche AK; Lioté F; So A; van Rij A; Jones GT; McCormick SP; Harrison AA; Stamp LK; Dalbeth N; Merriman TR
    Rheumatology (Oxford); 2016 Aug; 55(8):1421-30. PubMed ID: 27094595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the urate transporter SLC2A9 gene in susceptibility to gout in New Zealand Māori, Pacific Island, and Caucasian case-control sample sets.
    Hollis-Moffatt JE; Xu X; Dalbeth N; Merriman ME; Topless R; Waddell C; Gow PJ; Harrison AA; Highton J; Jones PB; Stamp LK; Merriman TR
    Arthritis Rheum; 2009 Nov; 60(11):3485-92. PubMed ID: 19877038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twenty-eight loci that influence serum urate levels: analysis of association with gout.
    Phipps-Green AJ; Merriman ME; Topless R; Altaf S; Montgomery GW; Franklin C; Jones GT; van Rij AM; White D; Stamp LK; Dalbeth N; Merriman TR
    Ann Rheum Dis; 2016 Jan; 75(1):124-30. PubMed ID: 25187157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiplicative interaction of functional inflammasome genetic variants in determining the risk of gout.
    McKinney C; Stamp LK; Dalbeth N; Topless RK; Day RO; Kannangara DR; Williams KM; Janssen M; Jansen TL; Joosten LA; Radstake TR; Riches PL; Tausche AK; Lioté F; So A; Merriman TR
    Arthritis Res Ther; 2015 Oct; 17():288. PubMed ID: 26462562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of the GCKR and A1CF loci with alcohol consumption to influence the risk of gout.
    Rasheed H; Stamp LK; Dalbeth N; Merriman TR
    Arthritis Res Ther; 2017 Jul; 19(1):161. PubMed ID: 28679452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GWAS of clinically defined gout and subtypes identifies multiple susceptibility loci that include urate transporter genes.
    Nakayama A; Nakaoka H; Yamamoto K; Sakiyama M; Shaukat A; Toyoda Y; Okada Y; Kamatani Y; Nakamura T; Takada T; Inoue K; Yasujima T; Yuasa H; Shirahama Y; Nakashima H; Shimizu S; Higashino T; Kawamura Y; Ogata H; Kawaguchi M; Ohkawa Y; Danjoh I; Tokumasu A; Ooyama K; Ito T; Kondo T; Wakai K; Stiburkova B; Pavelka K; Stamp LK; Dalbeth N; ; Sakurai Y; Suzuki H; Hosoyamada M; Fujimori S; Yokoo T; Hosoya T; Inoue I; Takahashi A; Kubo M; Ooyama H; Shimizu T; Ichida K; Shinomiya N; Merriman TR; Matsuo H;
    Ann Rheum Dis; 2017 May; 76(5):869-877. PubMed ID: 27899376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population-specific factors associated with fractional excretion of uric acid.
    Narang RK; Vincent Z; Phipps-Green A; Stamp LK; Merriman TR; Dalbeth N
    Arthritis Res Ther; 2019 Nov; 21(1):234. PubMed ID: 31718705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship of apolipoprotein B and very low density lipoprotein triglyceride with hyperuricemia and gout.
    Rasheed H; Hsu A; Dalbeth N; Stamp LK; McCormick S; Merriman TR
    Arthritis Res Ther; 2014 Nov; 16(6):495. PubMed ID: 25432151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional non-synonymous variants of ABCG2 and gout risk.
    Stiburkova B; Pavelcova K; Zavada J; Petru L; Simek P; Cepek P; Pavlikova M; Matsuo H; Merriman TR; Pavelka K
    Rheumatology (Oxford); 2017 Nov; 56(11):1982-1992. PubMed ID: 28968913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association analysis of the SLC22A11 (organic anion transporter 4) and SLC22A12 (urate transporter 1) urate transporter locus with gout in New Zealand case-control sample sets reveals multiple ancestral-specific effects.
    Flynn TJ; Phipps-Green A; Hollis-Moffatt JE; Merriman ME; Topless R; Montgomery G; Chapman B; Stamp LK; Dalbeth N; Merriman TR
    Arthritis Res Ther; 2013; 15(6):R220. PubMed ID: 24360580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population-specific influence of SLC2A9 genotype on the acute hyperuricaemic response to a fructose load.
    Dalbeth N; House ME; Gamble GD; Horne A; Pool B; Purvis L; Stewart A; Merriman M; Cadzow M; Phipps-Green A; Merriman TR
    Ann Rheum Dis; 2013 Nov; 72(11):1868-73. PubMed ID: 23349133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of the lipoprotein receptor-related protein 2 gene with gout and non-additive interaction with alcohol consumption.
    Rasheed H; Phipps-Green A; Topless R; Hollis-Moffatt JE; Hindmarsh JH; Franklin C; Dalbeth N; Jones PB; White DH; Stamp LK; Merriman TR
    Arthritis Res Ther; 2013 Nov; 15(6):R177. PubMed ID: 24286387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discordant association of the CREBRF rs373863828 A allele with increased BMI and protection from type 2 diabetes in Māori and Pacific (Polynesian) people living in Aotearoa/New Zealand.
    Krishnan M; Major TJ; Topless RK; Dewes O; Yu L; Thompson JMD; McCowan L; de Zoysa J; Stamp LK; Dalbeth N; Harré Hindmarsh J; Rapana N; Deka R; Eng WWH; Weeks DE; Minster RL; McGarvey ST; Viali S; Naseri T; Sefuiva Reupena M; Wilcox P; Grattan D; Shepherd PR; Shelling AN; Murphy R; Merriman TR
    Diabetologia; 2018 Jul; 61(7):1603-1613. PubMed ID: 29721634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Polynesian-specific copy number variant encompassing the MICA gene associates with gout.
    Wang K; Cadzow M; Bixley M; Leask MP; Merriman ME; Yang Q; Li Z; Takei R; Phipps-Green A; Major TJ; Topless R; Dalbeth N; King F; Murphy R; Stamp LK; de Zoysa J; Wang Z; Shi Y; Merriman TR
    Hum Mol Genet; 2022 Oct; 31(21):3757-3768. PubMed ID: 35451026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A strong role for the ABCG2 gene in susceptibility to gout in New Zealand Pacific Island and Caucasian, but not Māori, case and control sample sets.
    Phipps-Green AJ; Hollis-Moffatt JE; Dalbeth N; Merriman ME; Topless R; Gow PJ; Harrison AA; Highton J; Jones PB; Stamp LK; Merriman TR
    Hum Mol Genet; 2010 Dec; 19(24):4813-9. PubMed ID: 20858603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.